A new breast cancer risk prediction model combining histologic features of biopsied breast tissue from women with benign breast disease and individual patient demographic information more accurately classified breast cancer risk than the current screening standard. Results of a Mayo Clinic study comparing the new model to the current standard, the Breast Cancer Risk Assessment Tool (BCRAT), are published in the Journal of Clinical Oncology.
"Physicians routinely perform biopsies to evaluate concerning findings in the breast, either felt on exam or seen on mammogram, for the presence of a breast cancer," says Amy Degnim, M.D., a surgeon at Mayo Clinic and a senior author of the study. "However, about three-quarters of these biopsies prove to be benign and are referred to as benign breast disease (BBD)." Annually, more than a million American women have a biopsy with a benign finding and are left wondering if they will later develop breast cancer.
Dr. Degnim and her colleagues hypothesized that certain breast tissue findings, while benign, could help predict which women were at increased risk of developing breast cancer later. "Our new model more accurately classifies a woman's breast cancer risk after a benign biopsy than the BCRAT," Dr. Degnim says. Developed by the National Cancer Institute and the National Surgical Adjuvant Breast and Bowel Project, BCRAT is currently the most commonly used model for predicting breast cancer risk in women with BBD.
To test the new model, Dr. Degnim and her colleagues studied a cohort of approximately 10,000 women who had benign breast biopsies at Mayo Clinic and who received long-term follow-up for a later breast cancer occurrence. Using this cohort, researchers determined the age-specific incidence of breast cancer and death, and combined these estimates with a relative risk model derived from 377 patients who later developed breast cancer and 734 matched controls sampled from the Mayo Clinic BBD cohort. They validated the model using an independent set of women from the Mayo BBD cohort (378 patients with a later breast cancer and 728 matched controls) and compared the risk predictions from the new model with those from the BCRAT.
The concordance statistic from the new model was 0.665 in the model development series and 0.629 in the validation series; these values were higher than those from the BCRAT (0.567 and 0.472, respectively). The BCRAT significantly underpredicted breast cancer risk after benign biopsy (P .004), whereas predictions derived from the new model were appropriately calibrated to observed cancers (P .247).
"Since women with benign breast disease are at higher risk for breast cancer, optimal early detection is extremely important," Dr. Degnim says. "Ideally, women at increased risk for breast cancer should be identified so that we can offer appropriate surveillance and prevention strategies. Unfortunately, the BCRAT risk prediction model does not provide accurate estimates of risk for these women at the individual level."
Explore further: Women with atypical hyperplasia are at higher risk of breast cancer
Medical Xpress on facebook
Related Stories
Women with atypical hyperplasia are at higher risk of breast cancer
Dec 31, 2014
Women with atypical hyperplasia of the breast have a higher risk of developing breast cancer than previously thought, a Mayo Clinic study has found. Results of the study appear in a special report on breast ...
Cancer risk for African-American women with benign breast disease factors, study finds
Feb 11, 2013
A Wayne State University researcher has identified characteristics in benign breast disease associated with future cancer risk in African-American women.
What to know if breast cancer runs in your family
Oct 07, 2014
Breast cancer is the second leading cause of death from cancer in women. A woman's lifetime risk of developing breast cancer is 12 percent (1 of every 8 women). Breast cancer risk is higher among women whose close blood relatives ...
New exam nearly quadruples detection of invasive breast cancers in dense breast tissue
9 hours ago
A new breast imaging technique pioneered at Mayo Clinic nearly quadruples detection rates of invasive breast cancers in women with dense breast tissue, according to the results of a major study published this week in the ...
Novel breast tissue feature may predict woman's cancer risk
Oct 05, 2009
Mayo Clinic researchers have found that certain structural features within breast tissue can indicate a woman's individual cancer risk. The findings appear online today in the Journal of Clinical Oncology.
Recommended for you
Care eliminates racial disparity in colon cancer survival rates, study finds
35 seconds ago
For the past two decades, the National Cancer Institute has documented a persistent racial disparity in colon cancer survival rates in the United States.
Exercise regimen beneficial in head, neck CA radiation Tx
20 minutes ago
(HealthDay)—For patients with head and neck cancers undergoing radiation therapy, an exercise regimen is better than a repetitive swallow regimen for swallowing function, according to a study published ...
Cooperation between cancer cells makes therapies ineffective, suggests new treatment
1 hour ago
Cooperation between cancer cells makes current therapies ineffective but also suggests new treatment
Phase 1 clinical trial of CUDC-101 'throws kitchen sink' at head and neck cancer
1 hour ago
Head and neck cancer is among the few solid tumors whose incidence is increasing in the U.S. and outcomes have been slow to improve. Results of a phase 1 trial of the drug CUCD-101 with radiation and chemotherapy were reported ...
Study finds potential new drug target for lung cancer
4 hours ago
A new study by University of Kentucky Markey Cancer Center researchers suggests that targeting a key enzyme and its associated metabolic programming may lead to novel drug development to treat lung cancer.
An engineering approach from Virginia Tech helps breast cancer researchers at Georgetown
5 hours ago
Biologists working with engineers and physicists have found a molecule they say helps determine if breast cancer cells that are resistant to antiestrogen therapy will live or die.
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here to reset your password.
Sign in to get notified via email when new comments are made.
© Medical Xpress 2011-2014, Science X network
A new breast cancer risk prediction model combining histologic features of biopsied breast tissue from women with benign breast disease and individual patient demographic information more accurately classified breast cancer risk than the current screening standard. Results of a Mayo Clinic study comparing the new model to the current standard, the Breast Cancer Risk Assessment Tool (BCRAT), are published in the Journal of Clinical Oncology.
"Physicians routinely perform biopsies to evaluate concerning findings in the breast, either felt on exam or seen on mammogram, for the presence of a breast cancer," says Amy Degnim, M.D., a surgeon at Mayo Clinic and a senior author of the study. "However, about three-quarters of these biopsies prove to be benign and are referred to as benign breast disease (BBD)." Annually, more than a million American women have a biopsy with a benign finding and are left wondering if they will later develop breast cancer.
Dr. Degnim and her colleagues hypothesized that certain breast tissue findings, while benign, could help predict which women were at increased risk of developing breast cancer later. "Our new model more accurately classifies a woman's breast cancer risk after a benign biopsy than the BCRAT," Dr. Degnim says. Developed by the National Cancer Institute and the National Surgical Adjuvant Breast and Bowel Project, BCRAT is currently the most commonly used model for predicting breast cancer risk in women with BBD.
To test the new model, Dr. Degnim and her colleagues studied a cohort of approximately 10,000 women who had benign breast biopsies at Mayo Clinic and who received long-term follow-up for a later breast cancer occurrence. Using this cohort, researchers determined the age-specific incidence of breast cancer and death, and combined these estimates with a relative risk model derived from 377 patients who later developed breast cancer and 734 matched controls sampled from the Mayo Clinic BBD cohort. They validated the model using an independent set of women from the Mayo BBD cohort (378 patients with a later breast cancer and 728 matched controls) and compared the risk predictions from the new model with those from the BCRAT.
The concordance statistic from the new model was 0.665 in the model development series and 0.629 in the validation series; these values were higher than those from the BCRAT (0.567 and 0.472, respectively). The BCRAT significantly underpredicted breast cancer risk after benign biopsy (P .004), whereas predictions derived from the new model were appropriately calibrated to observed cancers (P .247).
"Since women with benign breast disease are at higher risk for breast cancer, optimal early detection is extremely important," Dr. Degnim says. "Ideally, women at increased risk for breast cancer should be identified so that we can offer appropriate surveillance and prevention strategies. Unfortunately, the BCRAT risk prediction model does not provide accurate estimates of risk for these women at the individual level."
Explore further: Women with atypical hyperplasia are at higher risk of breast cancer
Medical Xpress on facebook
Related Stories
Women with atypical hyperplasia are at higher risk of breast cancer
Dec 31, 2014
Women with atypical hyperplasia of the breast have a higher risk of developing breast cancer than previously thought, a Mayo Clinic study has found. Results of the study appear in a special report on breast ...
Cancer risk for African-American women with benign breast disease factors, study finds
Feb 11, 2013
A Wayne State University researcher has identified characteristics in benign breast disease associated with future cancer risk in African-American women.
What to know if breast cancer runs in your family
Oct 07, 2014
Breast cancer is the second leading cause of death from cancer in women. A woman's lifetime risk of developing breast cancer is 12 percent (1 of every 8 women). Breast cancer risk is higher among women whose close blood relatives ...
New exam nearly quadruples detection of invasive breast cancers in dense breast tissue
9 hours ago
A new breast imaging technique pioneered at Mayo Clinic nearly quadruples detection rates of invasive breast cancers in women with dense breast tissue, according to the results of a major study published this week in the ...
Novel breast tissue feature may predict woman's cancer risk
Oct 05, 2009
Mayo Clinic researchers have found that certain structural features within breast tissue can indicate a woman's individual cancer risk. The findings appear online today in the Journal of Clinical Oncology.
Recommended for you
Care eliminates racial disparity in colon cancer survival rates, study finds
35 seconds ago
For the past two decades, the National Cancer Institute has documented a persistent racial disparity in colon cancer survival rates in the United States.
Exercise regimen beneficial in head, neck CA radiation Tx
20 minutes ago
(HealthDay)—For patients with head and neck cancers undergoing radiation therapy, an exercise regimen is better than a repetitive swallow regimen for swallowing function, according to a study published ...
Cooperation between cancer cells makes therapies ineffective, suggests new treatment
1 hour ago
Cooperation between cancer cells makes current therapies ineffective but also suggests new treatment
Phase 1 clinical trial of CUDC-101 'throws kitchen sink' at head and neck cancer
1 hour ago
Head and neck cancer is among the few solid tumors whose incidence is increasing in the U.S. and outcomes have been slow to improve. Results of a phase 1 trial of the drug CUCD-101 with radiation and chemotherapy were reported ...
Study finds potential new drug target for lung cancer
4 hours ago
A new study by University of Kentucky Markey Cancer Center researchers suggests that targeting a key enzyme and its associated metabolic programming may lead to novel drug development to treat lung cancer.
An engineering approach from Virginia Tech helps breast cancer researchers at Georgetown
5 hours ago
Biologists working with engineers and physicists have found a molecule they say helps determine if breast cancer cells that are resistant to antiestrogen therapy will live or die.
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here
to reset your password.
Sign in to get notified via email when new comments are made.
© Medical Xpress 2011-2014, Science X network
0 comments:
Post a Comment